Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB003 in Advanced Gastrointestinal Stromal Tumors (GIST)
NCT07379047Phase 3Recruiting
- Sponsor
- Ningbo NewBay Technology Development Co., Ltd.
- Start
- May 2026
- Primary completion
- Aug 2028
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of NB003 in gastrointestinal stromal tumor (GIST), sponsored by Ningbo NewBay Technology Development Co., Ltd.. Started May 2026; status: recruiting.
02
Drugs
NB003
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT07379047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07379047.